Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes

Advances in Therapy

Volumn 27, Issue 9, 2010, Pages 623-633

  Deitelzweig, Steven B ^a   Lin, Jay ^b   Kreilick, Charles ^c   Hussein, Mohamed ^d   Battleman, David ^d  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b SANOFI   (France)

^c Pro Unlimited Inc   (United States)

^d IQVIA   (United States)

Author keywords

anticoagulation; prophylaxis; venous thromboembolism; warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; DEEP VEIN THROMBOSIS; DRUG EFFECT; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; COMORBIDITY; DATABASES, FACTUAL; DIAGNOSIS-RELATED GROUPS; DRUG MONITORING; FEMALE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; PATIENT READMISSION; PULMONARY EMBOLISM; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME MANAGEMENT; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; WARFARIN; YOUNG ADULT;

EID: 77956232181     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-010-0056-z     Document Type: Article

References (18)

1. R.H. White 2003 The epidemiology 1. of venous thromboembolism Circulation 107 suppl.1 I4 I8 12814979
2. R. Alikhan A.T. Cohen S. Combe, et al. 2004 Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study Arch Intern Med. 164 963 968 10.1001/archinte.164.9.963 15136304
3. M. Cushman A.W. Tsai R.H. White, et al. 2004 Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology Am J Med. 117 19 25 10.1016/j.amjmed.2004.01.018 15210384
4. P.O. Hansson J. Sörbo H. Eriksson 2000 Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors Arch Intern Med. 160 769 774 10.1001/archinte.160.6.769 1:STN:280: DC%2BD3c7pvFGgtQ%3D%3D 10737276
5. J.A. Heit D.N. Mohr M.D. Silverstein T.M. Petterson W.M. O'Fallon L.J. Melton 3rd 2000 Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study Arch Intern Med. 160 761 768 10.1001/archinte.160.6.761 1:STN:280:DC%2BD3c7pvFGgtA%3D%3D 10737275
6. D.N. Mohr M.D. Silverstein J.A. Heit T.M. Petterson W.M. O'Fallon L.J. Melton 2000 The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study Mayo Clin Proc. 75 1249 1256 10.4065/75.12.1249 1:STN:280:DC%2BD3M%2FntVSrug%3D%3D 11126832
7. R.H. White H. Zhou J. Kim P.S. Romano 2000 A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism Arch Intern Med. 160 2033 2041 10.1001/archinte.160.13.2033 1:STN:280:DC%2BD3czkslKnuw%3D%3D 10888977
8. C. Kearon M. Gent J. Hirsh, et al. 1999 A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism N Engl J Med. 340 901 907 10.1056/NEJM199903253401201 1:CAS:528:DyaK1MXit1aitb0%3D 10089183
9. C. Kearon S.R. Kahn G. Agnelli, et al. 2008 Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6suppl. 454S 545S 10.1378/chest.08-0658 1:CAS:528:DC%2BD1cXptVKhsrY%3D 18574272
10. M.A. Crowther J.B. Ginsberg C. Kearon, et al. 1999 A randomized trial comparing 5-mg and 10-mg warfarin loading doses Arch Intern Med. 159 46 48 10.1001/archinte.159.1.46 1:CAS:528:DyaK1MXmtVCjug%3D%3D 9892329
11. S.E. Kimmel Z. Chen M. Price, et al. 2007 The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) study Arch Intern Med. 167 229 235 10.1001/archinte.167.3.229 1:CAS:528: DC%2BD2sXisFyktb0%3D 17296877
12. J. Ansell J. Hirsh E. Hylek, et al. 2008 Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6suppl. 160S 198S 10.1378/chest.08-0670 1:CAS:528:DC%2BD1cXptVKiu7o%3D 18574265
13. US Department of Health & Human Services. Protection of Human Research Subjects. Available at: www.hhs.gov/ohrp/humansubjects/guidance/ 45cfr46.htm#46.101. Accessed February 23, 2010.
14. M.H. Prins B.A. Hutten M.M. Koopman H.R. Büller 1999 Long-term treatment of venous thromboembolic disease Thromb Haemost. 82 892 898 1:CAS:528:DyaK1MXnsVWmtbk%3D 10605799
15. C. Kearon J.S. Ginsberg M.J. Kovacs, et al. 2003 Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism N Engl J Med. 349 631 639 10.1056/NEJMoa035422 1:CAS:528:DC%2BD3sXmtl2gsrs%3D 12917299
16. R. Hull J. Hirsh R. Jay, et al. 1982 Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis N Engl J Med. 307 1676 1681 10.1056/NEJM198212303072704 1:STN:280:DyaL3s%2Fmt1Omuw%3D%3D 6755255
17. D. Ost J. Tepper H. Mihara O. Lander R. Heinzer A. Fein 2005 Duration of anticoagulation following venous thromboembolism: a meta-analysis JAMA 294 706 715 10.1001/jama.294.6.706 1:CAS:528:DC%2BD2MXns1CjsbY%3D 16091573
18. Schwarz M. Home monitoring of INR using point-of-care testing is a viable option for patient involvement (April 28, 2010). Available at: www.ismaap.org/index.php?id=636#c1170. Accessed June 23, 2010.